Jun-01-22 06:52AM | |
May-12-22 11:02AM | |
06:52AM | |
May-04-22 07:35PM | |
04:15PM | |
Apr-27-22 06:52AM | |
Mar-29-22 06:52AM | |
Mar-18-22 04:15PM | |
Mar-07-22 12:39PM | American City Business Journals |
Mar-04-22 05:33PM | |
04:15PM | |
02:34PM | American City Business Journals |
06:52AM | |
Feb-05-22 08:10AM | |
Feb-03-22 06:25PM | |
04:15PM | |
Jan-27-22 06:52AM | |
Jan-26-22 03:01PM | |
Jan-21-22 06:52AM | |
Dec-20-21 06:52AM | |
Nov-03-21 07:55PM | |
07:31PM | |
04:15PM | |
Oct-28-21 06:52AM | |
Oct-27-21 03:03PM | |
Sep-10-21 09:44AM | |
Aug-30-21 11:56AM | |
07:47AM | |
06:52AM | |
Aug-26-21 05:00AM | |
Aug-25-21 04:15PM | |
Aug-18-21 06:52AM | |
Aug-04-21 09:34AM | |
Jul-29-21 06:52AM | |
Jul-12-21 06:52AM | |
Jun-09-21 03:25AM | |
Jun-01-21 06:52AM | |
May-28-21 05:39PM | |
May-27-21 05:47PM | |
May-06-21 01:01AM | |
May-05-21 08:05PM | |
04:15PM | |
02:30PM | |
08:37AM | |
Apr-28-21 12:33PM | |
06:53AM | |
Apr-22-21 04:15PM | |
Apr-09-21 06:52AM | |
Apr-06-21 08:12AM | |
07:21AM | |
Apr-01-21 08:30AM | |
Mar-21-21 09:14PM | |
Mar-18-21 05:25PM | |
Mar-16-21 09:35PM | |
Mar-14-21 10:31PM | |
Mar-12-21 06:25AM | |
Mar-10-21 07:48AM | |
06:52AM | |
Mar-09-21 10:58PM | |
Mar-07-21 02:39PM | |
Mar-03-21 03:00AM | |
Feb-22-21 02:04PM | |
Feb-20-21 06:30PM | |
Feb-19-21 01:15AM | |
Feb-15-21 10:16PM | |
Feb-13-21 02:40PM | |
Feb-11-21 01:35PM | |
Feb-09-21 06:53AM | |
Feb-08-21 07:10PM | |
06:52AM | |
Feb-06-21 11:09PM | |
Feb-04-21 01:33PM | |
Feb-03-21 09:31PM | |
06:05PM | |
05:39PM | |
04:15PM | |
02:45PM | |
Jan-27-21 06:52AM | |
Dec-15-20 10:48AM | |
Dec-10-20 09:24PM | |
Dec-07-20 05:42PM | |
04:15PM | |
Nov-30-20 06:52AM | |
Nov-06-20 07:38AM | |
Nov-04-20 08:31PM | |
07:55PM | |
04:15PM | |
02:30PM | |
08:58AM | |
Nov-03-20 06:52AM | |
Oct-28-20 12:32PM | |
06:53AM | |
Aug-27-20 06:07AM | |
Aug-26-20 08:30PM | |
05:14PM | |
04:15PM | |
Aug-25-20 10:14AM | |
Aug-19-20 06:52AM | |
Aug-17-20 04:30PM | |
06:52AM | |
|
|
|
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
LEPORE PATRICK G | Director | May 16 | Buy | 0.54 | 50,000 | 27,000 | 487,145 | May 17 04:16 PM | FARBER JEFFREY | Director | Mar 17 | Buy | 0.81 | 20,000 | 16,200 | 2,152,454 | Mar 21 04:26 PM | Israel Samuel H | Chief Legal Officer | Feb 15 | Buy | 0.81 | 12,000 | 9,720 | 175,453 | Feb 15 05:45 PM | Chapman John C | Director | Feb 11 | Buy | 0.80 | 12,500 | 10,000 | 154,324 | Feb 15 05:46 PM | Abt John | Chief Quality and Operations | Feb 10 | Buy | 0.90 | 5,000 | 4,500 | 128,815 | Feb 11 04:31 PM | FARBER JEFFREY | Director | Feb 09 | Buy | 0.92 | 10,000 | 9,200 | 2,132,454 | Feb 10 05:16 PM | LEPORE PATRICK G | Director | Feb 08 | Buy | 0.88 | 50,000 | 44,000 | 437,145 | Feb 10 05:17 PM | KOZLOWSKI JOHN | VP of Finance & CFO | Dec 14 | Buy | 1.81 | 4,900 | 8,869 | 157,494 | Dec 14 04:26 PM | Crew Timothy C | Chief Executive Officer | Dec 13 | Buy | 1.99 | 20,000 | 39,800 | 584,270 | Dec 14 04:25 PM | KOZLOWSKI JOHN | VP of Finance & CFO | Dec 02 | Buy | 1.68 | 4,000 | 6,720 | 152,594 | Dec 02 04:18 PM | LEPORE PATRICK G | Director | Nov 29 | Buy | 1.71 | 50,000 | 85,500 | 387,145 | Nov 30 04:05 PM | FARBER JEFFREY | Director | Nov 17 | Buy | 1.93 | 10,000 | 19,300 | 2,122,454 | Dec 01 04:42 PM | KOZLOWSKI JOHN | VP of Finance & CFO | Nov 16 | Buy | 2.06 | 7,000 | 14,420 | 148,594 | Nov 16 04:13 PM | Rewolinski Melissa | Director | Sep 09 | Sale | 3.18 | 25,340 | 80,581 | 62,100 | Sep 13 04:09 PM | LEPORE PATRICK G | Director | Sep 08 | Buy | 3.31 | 20,000 | 66,200 | 337,145 | Sep 09 04:07 PM |
|